NCT02772562View on ClinicalTrials.gov

Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 18, 2016

Primary Completion Date

April 29, 2024

Study Completion Date

April 29, 2024

Conditions
Prostatic Neoplasms
Interventions
BIOLOGICAL

PROSTVAC-V/F

"0.5 ml containing at least 2 x 108 Infectious Units (Inf.U) PROSTVAC-V given on day 1.~0.5 ml containing at least 1 x 109 Inf.U PROSTVAC-F given on days 15, 28, 57, 85, 113, 141."

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

Sponsors

Collaborators (1)

Bavarian Nordic
All Listed Sponsors
collaborator

Bavarian Nordic

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT02772562 - Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy | Biotech Hunter | Biotech Hunter